Labeling of biotech salmon draws opposing views during public hearing

09/22/2010 | Wall Street Journal, The

During a public hearing conducted by the FDA on Tuesday, several consumer groups called on the agency to require AquaBounty Technology's biotech salmon, AquAdvantage, to carry a label indicating that it is genetically engineered. Meanwhile, AquaBounty and other industry representatives said the agency should comply with the current policies on labeling.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI